ÃÑ 99ÆäÀÌÁö

97ÆäÀÌÁö º»¹®½ÃÀÛ

¥³. ºÎ ·Ï ? 93
´Ù. Æǵ¶
1) ÃÖ¼Ò¾ïÁ¦³óµµ(MIC) °áÁ¤: MIC plate °¢ wellÀÇ Å¹µµ¸¦ ÃøÁ¤ÇÏ¿© ÃæºÐÇÑ ¼ºÀå ¾ïÁ¦°¡
ÀϾ Åõ¸íÇÑ »óÅ·Π³²¾ÆÀÖ´Â well Áß °¡Àå ÀûÀº ¾çÀÇ Ç×»ýÁ¦¸¦ Æ÷ÇÔÇÏ´Â wellÀÇ
Ç×»ýÁ¦ ³óµµ
2) Åõ¸íÇÏÁö ¾ÊÀº °æ¿ì´Â ±ÕÀÇ Áõ½ÄÀÌ ÀϾ °ÍÀ¸·Î ÆÇ´ÜÇÑ´Ù.
* Positive wellÀÇ ¼ºÀåÀ¯¹«¸¦ ¸ÕÀú È®ÀÎÇÑ ÈÄ Æǵ¶
Range
Breakpoints of
Breakpoints of
Antimicrobial
Antimicrobial Agents
tested
Staphylococcus
References
Streptococcus
References
subclass
(§¡/ml)
spp. (§¡/ml)
spp. (§¡/ml)
1)
-
Aminopenicillin
Ampicillin (AMP)
0.12-8
? 0.5
CLSI
3)
Cephalosporin¥°
Cephalothin (CEP)
2-16
? 32
CLSI
? 32
Pitkala A
2)
Cephalosporin¥²
Ceftiofur (XNL)
0.5-4
? 8
VET
? 8
VET08
Folate pathway
Sulphadimethoxine
32-256
? 512
CLSI
-
inhibitor
(SDM)
Lincosamide
Pirlimycin (PIRL)
0.5-4
? 4
VET
? 4
VET08
Macrolides
Erythromycin (ERY)
0.25-4
? 8
CLSI
? 1
M100
Penicillinase-
Pitkala A
3)
Penicillin (PEN)
0.12-8
? 0.25
CLSI
? 4
labile penicillins
Penicillinase-
Oxacillin +
? 0.5
-
2-4
CLSI
(S.aureus ? 4)
stable penicillins
2% NaCl (OXA+)
Penicillins/
Penicillin/
1/2-8/16
? 4/8
VET
? 4/8
VET08
Aminocoumarin
Novobiocin (P/N)
Tetracyclines
Tetracycline (TET)
1-8
? 16
CLSI
? 8
M100
1) Clinical Laboratory Standards Institute, M100, 2019
2) Clinical Laboratory Standards Institute, VET08, 2018
3) Pitkala A, Koort J, Bjorkroth J. J Dairy Sci. 2008; 91(10): 4075-81.

97ÆäÀÌÁö º»¹®³¡



ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
»ó´Ü¸Þ´º ¹Ù·Î°¡±â ´ÜÃàÅ°¾È³» : ÀÌÀüÆäÀÌÁö´Â ÁÂÃø¹æÇâÅ°, ´ÙÀ½ÆäÀÌÁö´Â ¿ìÃø¹æÇâÅ°, ùÆäÀÌÁö´Â »ó´Ü¹æÇâÅ°, ¸¶Áö¸·ÆäÀÌÁö´Â ÇϴܹæÇâÅ°, ÁÂÃøÈ®´ëÃà¼Ò´Â insertÅ°, ¿ìÃøÈ®´ëÃà¼Ò´Â deleteÅ°